Michael J Geuenich

5PUBLICATIONS
35CO-AUTHORS
Tumour immunologyInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsSemi- and unsupervised learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 26, 2026
Treg cells promote immunotherapy-induced immune evasion by restraining CD4 T cell control of MHC-I-deficient metastatic pancreatic cancer.

|May 26, 2025
HEB Restrains Effector Gene Expression during Early CD8+ Memory Precursor T Cell Differentiation.

Joanne Pui-Ting Leung, Siamak Haddadi, Michael J Geuenich

|Mar 12, 2025
IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8+ T cells Infiltrating Pancreatic Ductal Adenocarcinoma.

Zoe C Schmiechen, Hezkiel A Nanda, Adam L Burrack

|Jun 20, 2024
In vivo CRISPR screens reveal SCAF1 and USP15 as drivers of pancreatic cancer.

Sebastien Martinez, Shifei Wu, Michael Geuenich

|Feb 02, 2024
The impacts of active and self-supervised learning on efficient annotation of single-cell expression data.

Michael J Geuenich, Dae-Won Gong, Kieran R Campbell

Pageof 1

Frequent Collaborators

5 joint publications

Kieran R Campbell

2 joint publications

Grant H Hickok

2 joint publications

Audrey L Hilk

2 joint publications

Alexander K Tsai